Tag: LOTUS

Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

Financial by 0 comments

DUBLIN, Ireland and BRIDGEWATER, N.J. and NANTOU, Taiwan, July 31, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”) today announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA® (icosapent ethyl) across 10 countries, including nine in Southeast Asia […]

Continue Reading →

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Coronary/Structural Heart Regulatory by 0 comments

MARLBOROUGH, Mass., April 23, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge™ Aortic Valve System. Delivered via a minimally-invasive procedure, this transcatheter aortic valve replacement (TAVR) technology is approved for patients with severe aortic stenosis who are considered at […]

Continue Reading →

Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2017

Coronary/Structural Heart by 0 comments

MARLBOROUGH, Mass., Oct. 23, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced key data that will be presented at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Denver, on October 29 – November 2. WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device data will be featured in a […]

Continue Reading →